Clinical Trials
Capturing data at individual patient level allows clinicians to collect and track procedures, medicines, medical devices and additional patients care programmes during and after treatment. Enabling powerful data capture, Dendrite’s clinical trial software can be designed to suit any clinical research or scenario from specific diseases to clinical procedures.
Why use Dendrite's clinical trial software?
Dendrite's unique web-based clinical trials software can be accessed using a standard web-browser. Additional benefits of our clinical trial platform include:
- Accessed via secure, web-based software
- Comprehensive tracking of procedures
- Intuitive data capture with on line data validation
- Secure username and password access
- Automated validation of inclusion/exclusion criteria
- Automated randomisation
- Easy to use; employing standard check-boxes, radio-buttons and drop-down lists, which make for rapid data entry
- A drawing tool enables users to annotate diagrams, which can then be printed and stored in individual patient records
- PIN locking
- Secure encrypted web hosting
Please contact us if you wish to learn more about our clinical trial software.
Dendrite Clinical Systems is delighted to report that our Managing Director, Dr Peter Walton, has published a chapter discussing the value of clinical registries in new publication on Laparoscopic Sleeve Gastrectomy (LSG). In his Chapter, Dr Peter Walton outlines value of national bariatric registries and their capability to deliver evidence on a global basis, as well as providing some practical perspectives on best practice when setting out to start a national registry and how to keep a good registry going.
Dendrite Clinical Systems and the Institute for Health Research (IGES) in Berlin, Germany, have initiated the Outpatient Treatment of COVID-19 Infections (ABC-19) study, to record data on the treatment of COVID-19 patients and discover more about the outpatient course of the disease, the individual risk factors of patients that contribute to severe COVID-19 courses and the procedures of general practitioners (GPs).
Researchers at the University College London and University College London Hospitals NHS Foundation Trust), London, UK, have reported that the vast majority of participants with new onset loss of smell were positive for COVID19, and this acute loss of sense of smell needs to be considered globally as a criterion for self-isolation, testing and contact tracing in order to contain the spread of COVID-19.
Dendrite Clinical Systems’ innovative “Intellect Web” software has been chosen by an international group of 17 leading diabetes experts from the multidisciplinary Diabetes Surgery Summit (DSS), as the platform on which the CoviDiab project will establish a Global Registry to collect new cases of diabetes in patients with COVID-19.


